Saudi Arabia


HBI 2022: Balance of power in MENA is shifting

There is a risk, when looking at healthcare markets in MENA, of lumping all the countries together as one - but each market has very specific requirements, and very specific characteristics. A panel at HBI 2022 chaired by Hamid Yunis, partner at global law firm McDermott Will & Emery, investigated challenges and opportunities in the region - and how rapidly the markets are changing and why overseas players now need to work harder to impress.

Saudi Arabia backs new $400m hospital for Jordan

The University College London Medical School (UCLMS) is joining forces with the Saudi Jordanian Investment Fund (SJIF) and UCLA Health in a new $400 million (€380m) university hospital in Jordan.

Amanat targets post-acute care

Amanat, the listed, Dubai-based healthcare and education investor, sees big opportunities in post acute care as it reveals strong 2021 results.

Dallah Healthcare to buy stake in IMC after Amanat exit

Dallah Healthcare Company, a listed Saudi Arabian healthcare operator, has signed an agreement to buy 8.2% of the shares of a hospital in Jeddah, International Medical Centre (IMC). The move is part of Dallah Healthcare’s plan to gain a more than 25% stake in the hospital and increase its presence in Jeddah.

More questions for Babylon

The more you look at the Babylon SPAC deal, the more black box it looks. The sheer complexity of the US insurance system makes it impossible for investors to assess its prospects with any accuracy. And then there is the question of the $230m sale of shares made by "certain accredited investors". How much of this went to Babylon founder Ali Parsa?

Top Doctors raises $13m to boost growth

Top Doctors, the third biggest doctor-booking platform in private healthcare after EU-based Doctolib and global player DocPlanner, has raised $13m to improve its digital tools and grow in key sectors. HBI chats with Alberto E. Porciani, CEO of Top Doctors to find out more.

Diaverum rolls out algorithm to predict thrombosis

Vascular access thrombosis is an expensive and painful complication for dialysis patients, with an incident rate of 0.11-0.5 episodes per patient per year. Global dialysis provider Diaverum has started to roll out an algorithm that can predict 75% of cases missed by current practices, enabling earlier interventions.

HBI 2021: GCC investment approval now ‘takes five minutes’

Is healthcare in the Middle East and North Africa (MENA) the next big investment opportunity? According to a panel at HBI 2021 on the MENA region the answer is an emphatic yes, and the region is 'open for business - though not a market for the faint of heart.

Amanat sells minority stake in IMC

GCC-investor Amanat Holdings has sold its 13% stake in hospital International Medical Centre, a month after CEO Mohamad Hamade told HBI that it was shifting its strategy towards majority investments.

Find Us